Mustang Bio Insider Trades
NASDAQ: MBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 12:21 PM ET
Last 12 months
- Purchases
- 1 · $237.61
- Sales
- 2 · $241.43
- Shares bought / sold
- 247 / 251
- Net activity
- Net selling $4
Mustang Bio insider activity
Over the last 12 months, Mustang Bio insiders reported 5 transactions on SEC Form 4: 1 open-market purchase and 2 sales. Insiders bought $238 and sold $241 worth of stock, for net insider selling of $4. The largest seller was Herskowitz Neil, with $238 in reported sales.
The most recent filing shows Litchman Manuel MD (President, CEO and Interim CFO) reporting a transaction in 19 shares at $0.75 on Apr 24, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put MBIO's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
MBIO insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 24, 2026 | Litchman Manuel MDPresident, CEO and Interim CFO | Tax withholding | 19 | $14.25 | Form 4 |
| Jan 2, 2026 | Fortress Biotech, Inc.10% Owner | Award | 278,385 | — | Form 4 |
| Dec 30, 2025 | Jin DavidDirector | Buy | 247 | $237.61 | Form 4 |
| Dec 30, 2025 | Chill Adam J.Director | Sale | 4 | $3.82 | Form 4 |
| Dec 30, 2025 | Herskowitz NeilDirector | Sale | 247 | $237.61 | Form 4 |
| Sep 29, 2025 | Fortress Biotech, Inc.10% Owner | Award | 59,334 | — | Form 4 |
| Apr 24, 2025 | Litchman Manuel MDPresident, CEO and Interim CFO | Tax withholding | 27 | $33.48 | Form 4 |
| Mar 31, 2025 | Fortress Biotech, Inc.10% Owner | Award | 67,806 | — | Form 4 |
| Jun 27, 2024 | Fortress Biotech, Inc.10% Owner | Award | 575,191 | — | Form 4 |
| May 31, 2024 | Litchman Manuel MDPresident and CEO | Tax withholding | 1,396 | $488.60 | Form 4 |
| Jan 2, 2024 | Fortress Biotech, Inc.10% Owner | Award | 419,092 | — | Form 4 |
| Jul 5, 2023 | Herskowitz NeilDirector | Award | 7,246 | — | Form 4 |
| Jul 5, 2023 | WEISS MICHAEL SDirector | Award | 7,246 | — | Form 4 |
| Jul 5, 2023 | ROSENWALD LINDSAY A MDDirector | Award | 7,246 | — | Form 4 |
| Jul 5, 2023 | Chill Adam J.Director | Award | 7,246 | — | Form 4 |
| Jul 5, 2023 | ZELEFSKY MICHAEL JDirector | Award | 7,246 | — | Form 4 |
| Apr 24, 2023 | Litchman Manuel MDPresident and CEO | Award | 5,000 | — | Form 4 |
| Apr 24, 2023 | Litchman Manuel MDPresident and CEO | Tax withholding | 1,572 | $6.62K | Form 4 |
| Jan 6, 2023 | Fortress Biotech, Inc.10% Owner | Award | 2,807,008 | — | Form 4 |
| Sep 13, 2022 | ROSENWALD LINDSAY A MDDirector | Buy | 5,000 | $2.58K | Form 4 |
| Sep 13, 2022 | Litchman Manuel MDDirector | Buy | 5,000 | $2.58K | Form 4 |
| Jul 29, 2022 | WEISS MICHAEL SDirector | Award | 71,664 | — | Form 4 |
| Jul 29, 2022 | Chill Adam J.Director | Award | 71,664 | — | Form 4 |
| Jul 29, 2022 | Herskowitz NeilDirector | Award | 71,664 | — | Form 4 |
| Jul 29, 2022 | ROSENWALD LINDSAY A MDDirector | Award | 71,664 | — | Form 4 |
| Jul 29, 2022 | ZELEFSKY MICHAEL JDirector | Award | 71,664 | — | Form 4 |
| Jun 21, 2022 | Litchman Manuel MDDirector | Award | 61,000 | — | Form 4 |
| Apr 24, 2022 | Litchman Manuel MDPresident and CEO | Tax withholding | 1,248 | $15.16K | Form 4 |
| Mar 18, 2022 | ROSENWALD LINDSAY A MDDirector | Buy | 4,094 | $3.03K | Form 4 |
| Mar 18, 2022 | Litchman Manuel MDDirector | Buy | 5,000 | $3.69K | Form 4 |
| Dec 14, 2021 | Achenbach BrianSVP, Fin. & Corp. Controller | Sale | 4,374 | $8.00K | Form 4 |
| Dec 8, 2021 | Achenbach BrianSVP, Fin. & Corp. Controller | Award | 22,500 | — | Form 4 |
| Oct 27, 2021 | Litchman Manuel MDPresident and CEO | Buy | 65,000 | $145.60K | Form 4 |
| Oct 12, 2021 | Achenbach BrianSVP, Fin. & Corp. Controller | Sale | 4,450 | $10.15K | Form 4 |
| Aug 31, 2021 | Litchman Manuel MDPresident and CEO | Award | 2,746 | $7.08K | Form 4 |
| Aug 31, 2021 | ROSENWALD LINDSAY A MDDirector | Award | 1,170 | $3.02K | Form 4 |
| Jul 30, 2021 | Litchman Manuel MDPresident and CEO | Buy | 86,206 | $250.86K | Form 4 |
| Jun 28, 2021 | ROSENWALD LINDSAY A MDDirector | Award | 13,774 | — | Form 4 |
| Jun 28, 2021 | Chill Adam J.Director | Award | 13,774 | — | Form 4 |
| Jun 28, 2021 | Herskowitz NeilDirector | Award | 13,774 | — | Form 4 |
| Jun 28, 2021 | WEISS MICHAEL SDirector | Award | 13,774 | — | Form 4 |
| Jun 28, 2021 | ZELEFSKY MICHAEL JDirector | Award | 13,774 | — | Form 4 |
| Jun 17, 2021 | Litchman Manuel MDPresident and CEO | Award | 61,000 | — | Form 4 |
| Apr 9, 2021 | Achenbach BrianSVP, Fin. & Corp. Controller | Sale | 2,423 | $8.14K | Form 4 |
| Mar 5, 2021 | Litchman Manuel MDPresident and CEO | Buy | 165,562 | $516.55K | Form 4 |
| Feb 26, 2021 | Litchman Manuel MDPresident and CEO | Award | 5,000 | $14.15K | Form 4 |
| Dec 8, 2020 | Achenbach BrianSVP, Fin. & Corp. Controller | Sale | 5,185 | $15.71K | Form 4 |
| Oct 21, 2020 | Achenbach BrianSVP, Fin. & Corp. Controller | Sale | 3,056 | $9.08K | Form 4 |
| May 22, 2020 | Achenbach BrianSVP, Fin. & Corp. Controller | Sale | 880 | $2.68K | Form 4 |
| May 22, 2020 | Litchman Manuel MDPresident and CEO | Sale | 8,348 | $25.38K | Form 4 |
| May 22, 2020 | Litchman Manuel MDPresident and CEO | Sale | 4,025 | $12.24K | Form 4 |
| Mar 31, 2020 | Achenbach BrianSVP, Fin. & Corp. Controller | Sale | 3,033 | $8.01K | Form 4 |
| Dec 6, 2019 | Achenbach BrianSVP, Fin. & Corp. Controller | Sale | 6,144 | $22.67K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4